FDA 483 - Brassica Pharma Private Ltd - January 19, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Brassica Pharma Pvt Ltd, a sterile drug manufacturer, revealed severe deficiencies in laboratory controls and aseptic processing. The firm was cited for fabricating laboratory records for unperformed sterility and environmental monitoring tests, failing to adequately validate its aseptic and sterilization processes, and exhibiting poor aseptic techniques during manufacturing. These critical issues indicate a high risk of microbiological contamination in their sterile drug products.
ID · 12829314-79a7-49a9-9bbf-fd2c8c9b5ca4